| CAS No.: | Lapatinib Ditosylate |
|---|---|
| Certification: | REACH |
| Appearance: | Powder |
| Color: | White |
| Content: | 99% |
| Transport Package: | 25kg/Kraft Paper Bag |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Henan puca Chemical Technology Co., LTD is an enterprise committed to the development, production, sales and transportation of chemical products. The company has a long-term cooperative relationship with Beijing Research Institute of Chemical Industry and its affiliated universities at home and abroad. It is a research and development enterprise of new chemical materials for the global chemical market demand. "Continuous innovation, quality assurance" is our purpose. It integrates the research and development, industrialization and marketization of innovative chemical new materials. The company has strong technical strength, advanced equipment, strict quality management system and quality after-sales service. Over the years, our products have been widely sold to many countries and regions, and we have established stable cooperative relations with traders and end users all over the world. Relying on a strong logistics system, we have established our own overseas warehouses in the United States, Mexico, Canada and the Netherlands. Hot local products can be shipped from overseas warehouses. Well received by local customers. It has become a powerful bridge between suppliers, traders and end users. We look forward to more cooperation with you.
Lapatinib ditosylate powder cas 388082-77-7
Breast cancer remains a leading cause of disease and death among women throughout the world. Despite advances in drug therapy, development of novel and improved drugs for breast cancer continues to be of great interest. Lapatinib is a novel dual receptor tyrosine kinase inhibitor that is a selective and potent inhibitor of ErbB-1 and ErbB-2 tyrosine kinases, both of which are growth promoting factors overexpressed in some breast cancers.
Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt (trade name TYKERB). Lapatinib is dual inhibitor of the EGFR (epidermal receptor; also called HER1 or ErbB1) and HER2 receptor tyrosine kinases. Lapatinib was developed by GlaxoSmithKline, however, Novartis subsequently acquired all the rights to the drug from GlaxoSmithKline. TYKERB is indicated in combination therapy for the treatment of metastatic breast cancer that overexpresses the HER2 receptor.
We have our own warehouses in Australia, the United States, Germany, Canada and other countries, which greatly saves shipping time and customers can receive their packages faster. In addition, customers can also choose door-to-door pickup service.Provide professional and efficient services to speed up your goods delivery time
Service:
1. Any inquiries will be replied within 12 hours.Q1: How to confirm the product quality before placing an order?
1. You can get some samples of products.
2. You can also send us the specifications or your requirements, and we will customize the product for you.
Q2: How can I contact you?
Contact us via email or Whatsapp. Average response time is 0-4 hours during working hours and less than 24 hours during non-working hours.
Q3: How to place an order?
--Contact us in any of the above ways..
--Leave us a message with the product you want.
--Description of order Quantity.
--Please tell us your shipping address.
--The sales manager gives you a quotation.
--Same day delivery after payment.
https://pukaxincailiao.en.made-in-china.com/contact-info.html
Suppliers with verified business licenses
){kind=link}
){kind=link}